In the fast-evolving landscape of targeted cancer therapies, polyethylene glycol (PEG) linkers play a pivotal role in the design and efficacy of antibody-drug conjugates (ADCs). Among the many suppliers in this competitive field, Watson, the brand owner of ChemWhat®, has emerged as a globally recognized leader, renowned for its high-purity PEG linkers that meet the rigorous demands of advanced pharmaceutical research and development.
https://www.youtube.com/watch?v=CV3kAvGecSg
https://www.youtube.com/watch?v=CV3kAvGecSg
Comments
Post a Comment